Fasenra approved in China for the treatment of severe eosinophilic asthma
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
These accolades highlight our unwavering commitment to maintaining the highest safety standards
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Subscribe To Our Newsletter & Stay Updated